Levent ALBAYRAK, Atakan SAVRUN, Emre GÖKÇEN, İbrahim ÇALTEKİN, Dilek ATİK, Hasan Burak KAYA, Bilgehan DEMİR

Evaluation of red blood cell distribution width and mean platelet volume levels in hypertensive and non-hypertensive epistaxis patients

Aim: We investigated the development of epistaxis and the effect of red blood cell distribution (RDW) and mean platelet volume(MPV) levels in hypertensive patients compared to non-hypertensive patients. Epistaxis is an urgent rhinologic condition that maymanifest itself as recurrent hemorrhages in small quantities or life-threatening hemorrhages. It is known that epistaxis does notdevelop in every hypertensive patient.Material and Methods: In this retrospective study, the participants were divided into four groups as follows: Group 1 hypertensiveepistaxis, Group 2 isolated epistaxis, Group 3 isolated hypertension, Group 4 control. RDW and MPV values were obtained fromcomplete blood count (CBC) samples.Results: There was a statistically significant difference in RDW and MPV blood parameters between all groups (p=0.02). When RDWand MPV blood parameters of Group 1 with hypertensive epistaxis and Group 3 with isolated hypertension were evaluated, there wasa statistically significant difference between these two groups in both parameters (p = 0.000, p = 0.011).Conclusion: In our study, we showed that the decrease in RDW and MPV values among the hematological parameters increases theassociation of epistaxis with hypertension in hypertensive patients compared to non-hypertensive patients.

PDF

___

1. Sarhan NA, Algamal AM. Relationship between epistaxis and hypertension: A cause and effect or coincidence? J the Saudi Heart Association 2015;27:79-84.
2. Agreda B, Urpegui Á, Alfonso JI, et al. Ligation of the sphenopalatine artery in posterior epistaxis. Retrospective study of 50 patients. Acta Otorrinolaringolog (English Edition) 2011;62:194-8.
3. Chiu TW, Shaw-Dunn J, McGarry GW. Woodruff’s plexus. J Laryngol Otol 2008;122:1074-7.
4. Lippi G, Salvagno GL, Danese E. Variation of red blood cell distribution width and mean platelet volume after moderate endurance exercise. Adv Hematol 2014;2014:192173.
5. Kemal O, Müderris T, Sevil E, et al. Relation of mean platelet volume and red blood cell distribution width with epistaxis. Laryngoscope 2015;125:788-90.
6. 6. Feng X, Zhang JY, Jiang L, et al. In reference to Relation of mean platelet volume and red blood cell distribution width with epistaxis.Laryngoscope 2015;125:223.
7. Bezgin SÜ, Çakabay T, Al IO. Assessment of red blood cell distribution width and mean platelet volume in children with epistaxis. Int J Pediatr Otorhinolaryngol 2017;95:20-3.
8. Karabulut AE, Çevik Y, Emektar E, et al. Analysis of mean platelet volume and red blood cell distribution width in recurrent epistaxis. Turk J Emerg Med 2018;18:67-70.
9. Aksakal C, Şahin M. Evaluation of neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio in recurrent epistaxis in childhood: case controlled study. Pan Afr Med 2019;32:154.
10. Herkner H, Laggner AN, Müllner M, et al. Hypertension in patients presenting with epistaxis. Ann Emerg Med 2000;35:126-30.
11. Fuchs FD, Moreira LB, Pires CP, et al. Absence of association between hypertension and epistaxis: a population-based study. Blood pressure 2003;12:145- 8.
12. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens 2014;16:14-26.
13. Yadav R, Bhartiya JP, Verma SK, et al. Evaluation of blood urea, creatinine and uric acid as markers of kidney functions in hypertensive patients: a prospective study.Indian J Med Res 2014;3:682-9.
14. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536.
15. Celik T, Iyisoy A, Yuksel UC, et al. A new evidence of end-organ damage in the patients with arterial hypertension: epistaxis? Int J Cardiol 2010;141:105-7.
16. Kikidis D, Tsioufis K, Papanikolaou V, et al. Is epistaxis associated with arterial hypertension? A systematic review of the literature.Eur Arch Otorhinolaryngol 2014;271:237-43.
17. Middleton PM. Epistaxis. Emerg Med Australas 2004;16:428-40.
18. Sunbul M, Gerin F, Durmus E, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens 2014;36:217-21.
19. Doğruyol S, Korçak MF, Özpolat Ç, et al. Epistaxis in emergency room: Is routine blood work always necessary? Bosphorus Medical J 2017;4:89-94.